share_log

Credit Suisse Maintains Neutral on Cano Health, Lowers Price Target to $0.5

Benzinga ·  Aug 14, 2023 20:08

Credit Suisse analyst A.J. Rice maintains Cano Health (NYSE:CANO) with a Neutral and lowers the price target from $2.5 to $0.5.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment